Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Centr Brands Corp CNTRF


Primary Symbol: C.CNTR

Centr Brands Corp. is a Canada-based wellness beverage company. The Company is engaged in development and marketing of beverages infused with hemp-derived extracts and derivatives. The Company is focused on the sales and development of a non-alcoholic beverages for cannabidiol (CBD) infused beverage industry. It offers a range of functional wellness beverages that support individuals in their... see more

CSE:CNTR - Post Discussion

Centr Brands Corp > New FDA Commissioner Has Hemp Groups ‘Cautiously Optimistic’
View:
Post by EndZonefor7 on Feb 17, 2022 10:38am

New FDA Commissioner Has Hemp Groups ‘Cautiously Optimistic’

This is a major development towards full FDA approval this year opening up entry into big box stores like Costco, Walmart etc. 

-------------------------------------------------------------------------------------------



"In his previous role as commissioner, Califf has expressed support of cannabis and cannabinoid research for medical applications. 

“The [FDA] is supportive of scientific research and of the medical uses of marijuana and its constituents when done through scientifically valid investigations and as part of the FDA's drug review and approval process,” Califf said during a neuroscience research summit held in 2016.

In fact, Califf said during the summit that he had prescribed cannabinoid-based medicine to some of his patients who experienced heart failure–a fact the National Industrial Hemp Council (NIHC) sees as promising for the advancement of the industry.

“Our industry has reason to be cautiously optimistic that the FDA is now led by a physician who has previously prescribed cannabinoids to his patients. We look forward to working with Dr. Califf on a commonsense regulatory framework that promotes the safe use of hemp in supplements, food and animal feed,” said Patrick Atagi, president and CEO of the NIHC, in a written statement.


https://www.hempgrower.com/article/new-fda-commissioner-robert-califf-hemp-groups-cautiously-optimistic-industry-advancement/

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities